TTM alone can specifically target neuroblastoma cells as demonstrated by its strong inhibitory effect on oxygen consumption by SK‐N‐BE(2) cells and lack of this effect on normal fibroblasts and neuronal cells (Fig. 6A). This evidence concerns the gene SLITRK1 and neuroblastoma.